Mural Health Technologies has filed a notice of an exempt offering of securities to raise $12,730,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Mural Health Technologies is raising up to $12,730,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Samuel Whitaker played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Mural Health Technologies
Mural Health is a clinical trials technology company that is dedicated to making it easy to be a participant in clinical trials. Mural Healths technology platform, Mural Link, is a patient-first technology that is primarily designed to benefit the study participant but also improves site operations and drives critical strategic value to study sponsors.
To learn more about Mural Health Technologies, visit http://www.muralhealth.com/
Contact:
Samuel Whitaker, Chief Executive Officer
267-550-0936
https://www.linkedin.com/in/sam-whitaker/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.